Outcome of Japanese patients with cirrhosis due to nonalcoholic steatohepatitis(NASH) and hepatitis C

被引：0
|
作者：
Yatsuji, Satoru
Hashimoto, Etsuko
Kabutake, Ayae
Tobari, Maki
Taniai, Makiko
Tokushige, Katsutoshi
Shiratori, Keiko
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A812 / A812
页数：1
相关论文
共 50 条
  • [1] Peculiarities of Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)
    El-Sherif, Omar
    Armstrong, M. J.
    SEMINARS IN LIVER DISEASE, 2020, 40 (01) : 1 - 10
  • [2] Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C
    Sanyal, AJ
    Banas, C
    Sargeant, C
    Luketic, VA
    Sterling, RK
    Stravitz, RT
    Shiffman, ML
    Heuman, D
    Coterrell, A
    Fisher, RA
    Contos, MJ
    Mills, AS
    HEPATOLOGY, 2006, 43 (04) : 682 - 689
  • [3] Genetic background of Japanese patients with nonalcoholic steatohepatitis (NASH)
    Saibara, T
    Namikawa, C
    Zhang, SP
    Ma, RH
    Nozaki, Y
    Nemoto, Y
    Ono, M
    Akisawa, N
    Iwasaki, S
    Hiroi, M
    Enzan, H
    Onishi, S
    NASH AND NUTRITIONAL THERAPY, 2005, : 58 - 63
  • [4] Predictors of nonalcoholic steatohepatitis in Japanese patients: Thioredoxin and NASH
    Okanoue, T
    Yamauchi, N
    Furutani, M
    Hirohama, A
    Sumida, Y
    Nakashima, T
    NASH AND NUTRITIONAL THERAPY, 2005, : 64 - 72
  • [5] Serum bile acids are markedly elevated in patients with compensated cirrhosis due to nonalcoholic steatohepatitis (NASH)
    Sanyal, A.
    Harrison, S.
    Charlton, M.
    Caldwell, S.
    Chuang, J.
    Wang, L.
    Chen, G.
    Chung, C.
    Djedjos, S.
    Myers, R.
    Afdhal, N.
    Bosch, J.
    Ratziu, V.
    Loomba, R.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S550 - S551
  • [6] EVALUATION OF THE NASH-CHECK PATIENT-REPORTED OUTCOME INSTRUMENT FOR PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) WITH COMPENSATED CIRRHOSIS
    Doward, Lynda
    Twiss, James
    Breckons, Matthew
    Balp, Maria-Magdalena
    Pettersson, Billie
    McSweeney, Lorraine
    Oluboyede, Yemi
    Vale, Luke
    Brass, Clifford
    Anstee, Quentin M.
    Sanyal, Arun J.
    HEPATOLOGY, 2021, 74 : 1007A - 1007A
  • [7] THE PREVALENCE OF HEPATITIS-C AND HEPATITIS-B IN NONALCOHOLIC STEATOHEPATITIS (NASH)
    WEINSTEIN, JS
    LASKUS, T
    RAKELA, J
    PERSING, DH
    CRIPPIN, JS
    MCGILL, DG
    GORES, GJ
    POWIS, PE
    LINDOR, KD
    HEPATOLOGY, 1993, 18 (04) : A220 - A220
  • [8] Baseline characteristics of patients with and without diabetes in trials for advanced fibrosis/cirrhosis due to nonalcoholic steatohepatitis (NASH)
    Romero-Gomez, M.
    Calleja, J.
    Crespo, J.
    Garcia-Samaniego, J.
    Augustin, S.
    Turnes, J.
    Younossi, Z. M.
    Eric, L. J.
    Wong, V. W.
    Okanoue, T.
    Trauner, M.
    McColgan, B. J.
    Harrison, S. A.
    Quentin, A. M.
    DIABETOLOGIA, 2019, 62 : S529 - S530
  • [9] CIRRHOSIS REGRESSION IS ASSOCIATED WITH IMPROVED CLINICAL OUTCOMES IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
    Sanyal, Arun J.
    Anstee, Quentin M.
    Trauner, Michael H.
    Lawitz, Eric J.
    Abdelmalek, Manal F.
    Ding, Dora
    Han, Ling
    Jia, Catherine
    Camargo, Marianne
    Kersey, Kathryn
    Myers, Robert P.
    Wong, Vincent
    Okanoue, Takeshi
    Romero-Gomez, Manuel
    Muir, Andrew Joseph
    Afdhal, Nezam H.
    Bosch, Jaime
    Goodman, Zachary D.
    Harrison, Stephen A.
    Younossi, Zobair M.
    HEPATOLOGY, 2020, 72 : 67A - 68A
  • [10] Nonalcoholic Steatohepatitis (NASH)-Associated Hepatocellular Carcinoma without Cirrhosis
    Kim, Alexander
    Miao, Chuan
    Pineda, John
    Haider, Fyeza
    Johal, Amitpal
    Smith, Robert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S158 - S158
12345